Get Started

NUVB

NYSE Nuvation Bio, Inc. Class A
Oct 29, 2026 · 12:47 AM ET EOD Market Closed

$4.59 ↑ +0.00 (+0.00%) Trading Up from the previous close of $4.59, $0.01 below the day’s high of $4.60

YTD change
-48.77%
vs 20-day SMA
-5.23%
vs 200-day SMA
-15.37%

Price ranges

Previous day
$4.36 $4.59
open $4.49 close $4.55
+$0.06 (+1.34%)
Today
$4.43 $4.60
open $4.48 now $4.59
+$0.11 (+2.46%)
Past week
$4.36 $4.96
from $4.77 now $4.59
-$0.18 (-3.77%)
Past month
$4.35 $5.83
from $5.62 now $4.59
-$1.03 (-18.33%)
This year
$4.05 $9.10
from $8.96 now $4.59
-$4.37 (-48.77%)

Price & Performance

+0.03 (+0.66%) / 6M

$3.97$5.15$6.32$7.50Apr 28Jul 29Oct 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 69.9% away from all-time highs of $15.23
  • NUVB is down 49% since the beginning of the year
  • NUVB is down 15% over the past 12 months
  • NUVB is down 18% over the past 1 month
  • 25% of all NUVB investors are betting against NUVB
  • Number of investors short NUVB has gone up 17% versus last month

NUVB reads not so good: price sits below both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is -14.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.18
Earnings momentum -45.7% Quarterly EPS growth
Quarterly change -45.7%

Valuation

P/E ratio N/A
Enterprise value $1.3B
Beta 2.16

Balance sheet & scale

IncomeN/A
Revenue$169.9M
Cash$661.0M
Debt$416.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Other Services (except Public Administration)
Sub Sector Religious, Grantmaking, Civic, Professional, and Similar Organizations
Market cap $1.6B

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Competitor comparison

TickerCompany PriceChange
CCAP Crescent Capital BDC, Inc. $9.01 +1.24%
GENRF Generation Uranium Inc Class A $0.0257 +3.71%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.